Table of Contents
Volume 16 Issue 4
Volume 16 Issue 2-3
Volume 16 Issue 1
Volume 15 Issue 4
Volume 15 Issue 3
Volume 15 Issue 2
Volume 15 Issue 1
Volume 14 Issue 4
Volume 14 Issue 3
Volume 14 Issue 2
Volume 14 Issue 1
Volume 13 Issue 4
Volume 13 Issue 3
Volume 13 Issue 2
Volume 13 Issue 1
Volume 12 Issue 4
Volume 12 Issue 3
Volume 12 Issue 2
Volume 12 Issue 1
Volume 11 Issue 4
Volume 11 Issue 3
Volume 11 Issue 2
Volume 11 Issue 1
Volume 10 Issue 4
Volume 10 Issue 3
Volume 10 Issue 2
Volume 10 Issue 1
Volume 9 Issue 4
Volume 9 Issue 3
Volume 9 Issue 2
Volume 9 Issue 1
Dr. Prasad S. Koka
Professor, Stem Cell Biology
Biomedical Research Institute of Southern California
Oceanside, California, USA
Featured Scientific Article by Dr. Prasad S. Koka
“Biomarker Discovery and Biotherapeutics Applications of Photosynthetic Light-Harvesting and Bioluminescence Light-Emitting Chromophore-Protein Complexes in Stem Cell Biology and Regenerative Medicine”
This article is available via Open Access: “Biomarker Discovery and Biotherapeutics Applications of Photosynthetic Light-Harvesting and Bioluminescence Light-Emitting Chromophore-Protein Complexes in Stem Cell Biology and Regenerative Medicine”
Dr. Inger Birgitta Sundell-Ranby
Department of Anthropology
Wayne State University
Detroit, Michigan, USA
EDITORIAL ADVISORY BOARD
Dr. Richard K. Burt
Division of Immunotherapy, Department of Medicine
Northwestern University Feinberg School of Medicine
Chicago, Illinois, USA
Dr. Connie J. Eaves
Terry Fox Laboratory
University of British Columbia
Vancouver, British Columbia, Canada
Dr. Ahmed El-Hashash
Biomedicine, Stem Cell & Regenerative Medicine
University of Edinburgh-ZJU Institute
Haining, Zhejiang, China
Dr. Stan Gronthos
University of Adelaide
Dr. Wasim Khan
University of Cambridge and Addenbrooke’s Hospital
Trauma and Orthopaedic Surgery
Dr. Tomohiko Kisaka
Translational Research Center, Hiroshima University
School of Biodesign, All India Institute of Medical Sciences
AIIMS | Hiroshima Uni | IIT Delhi | BCIL | Tottori Uni
Dr. Toshio Kitamura
The Institute of Medical Science
University of Tokyo
Dr. J. Michael McCune
Chief, Division of Experimental Medicine
University of California at San Francisco
San Francisco, California, USA
Dr. Michel Puceat
INSERM UMR 910
Faculté de Médecine La Timone
13885 Marseille, France
Dr. Christina M. Ramirez
Professor of Biostatistics
UCLA Fielding School of Public Health
Los Angeles, California, USA
Dr. David Scadden
Harvard Department of Stem Cell and Regenerative Biology
Massachusetts General Hospital
Boston, Massachusetts, USA
Dr. Alka Sharma
Department of Biotechnology
Ministry of Science and Technology
New Delhi, Delhi, India
Dr. Sarah E. Webb (Ho)
Division of Life Science
HKUST, Clear Water Bay
Kowloon, Hong Kong
Palas Kumar Chanda, Houston Methodist Research Institute, Houston, TX, USA
Debamitra Das, Staff Scientist, Lieber Institute for Brain Development, Baltimore, MD, USA
Indulekha Pillai, University of California, Los Angeles, CA, USA
Pavan Rajanahalli, University of Tampa, Tampa, FL, USA
Rajesh Ranjan, PhD, Department of Biology, Johns Hopkins University, Baltimore, MD, USA
Kanchan Sarda, Department of Orthopaedic Surgery, University of California, San Francisco, CA, USA
Pulavendran Sivasami, Emory University School of Medicine, Atlanta, GA, USA
Jinyun Yuan, Washington University School of Medicine, St. Louis, MO, USA
NOTES FOR CONTRIBUTORS
Journal of Stem Cells is a peer-reviewed journal that publishes four issues per year. The journal is owned and operated by Nova Science Publishers and funded entirely by subscription revenue and author-optional publication services.
Instructions for Reviewers
Reviewers who repeatedly decline to review manuscripts following their formal inclusion on the journal’s website will be removed from the list of reviewers at the Editor’s discretion.
Serving reviewers are advised to recommend their colleagues in the event they are unable to review the assigned manuscript.
Contributing authors can also recommend referees in their fields of expertise for reviewing their articles if there is no conflict of interest.
Notes for Authors
There is no charge to submit your article and have it published in the journal, and there is no charge for color printing. Nova offers a number of optional publication services that carry fees, but authors are not required to select these services, and the services won’t be offered until after acceptance of the articles. These services include Open Access, article offprints, discounted print copies of the journal issue, and licenses for use of the published articles.
Submission of an article must be accompanied by a signed Copyright Transfer and Disclosure Form, which can be printed or downloaded here: https://novapublishers.com/wp-content/uploads/2021/09/CTDF-Copyright-Transfer-and-Disclosure-Form.pdf. Submissions that do not include a signed Copyright Transfer and Disclosure Form will be treated as incomplete.
Authors will receive complimentary PDFs of their final articles upon publication. Print copies will be offered at a discount.
Authors may deposit and display the proofed versions of their articles in and on their personal non-commercial and affiliate non-commercial repositories and websites at any time. The same may be done with their final published articles only after a period of one year has elapsed from the day of publication.
Original or review articles submitted to Journal of Stem Cells are sent for peer review to at least three reviewers. This number of reviewers can increase if some of the reviewers fail to respond, or if there is a conflict between the reviewers on the decision making process by the Editor. If some of the reviewers’ comments are severely adverse in nature then the Editor will seek the response of additional reviewer(s). A final decision to accept or reject the article is made by the Editor after seeking a suitable response from the authors to the reviewers’ comments. The revised version of the article may be sent back to the same reviewers before a decision is made. The authors’ responses and rebuttals on the reviewer(s) comments on the revised version of the manuscript will determine the decision of acceptance or rejection of the manuscript / article.
Journal of Stem Cells has ceased publication and is no longer accepting submissions. The journal and its editors have transitioned to a new book series titled Stem Cells in Translational Biomedicine, linked here: https://novapublishers.com/product-category/series/stem-cells-in-translational-biomedicine/
Before submitting your article, please read the complete notes and instructions below to ensure that you understand Nova’s manuscript requirements and publication procedures and that you are in compliance with the ethical standards rightfully set forth by Nova, the publishing industry, and the scientific community.
All abstracts and articles must be written in English with references in standard Roman script.
It is understood that articles submitted to the journal have not been submitted elsewhere for simultaneous publication consideration and have not been previously published, in whole or in part, unless the new article is an expansion of the original, in which case full transparency of the re-used portions must be provided. Please note that articles cannot be retracted or withdrawn after they have been published.
The Journal will be published in the standard letter size with soft cover. The articles will include peer-reviewed original research and review articles, brief reports, rapid communications, mini- or short reviews, news items, book reviews, and letters to the Editor. Regular research articles will consist of an abstract, introduction, materials and methods, results, discussion, acknowledgements, table and figure legends, and references.
The word count limitations for all submissions will be considered on case-by-case basis with importance to the delivery of the scientific information to the readers. Cover illustration of scientific significance for a specific issue of the Journal from a contributing author will be considered by the Editor in consultation with the Publisher. The authors will submit to the Editor an electronic version of the article including cover letter, text, tables, figures, and illustrations as accepted for publication. The Editor reserves the right to reject publication of an article that does not meet these requirements or in his opinion is not original. Personal and institutional subscriptions are available.
An average issue will constitute between 100-150 pages and will be 8.5 x 11 double column. Contributors trying to submit articles above 4MB in size should contact the Editor for instructions on how to submit the article through our FTP server. For final submission of publication, the manuscript text should be in MS Word and the figures, graphics, and illustrations should be in TIFF format.
In-text references should be either author-identified or reference-number-identified and placed in square brackets on the line, e.g., . Examples of acceptable forms of reference lists at the end of the article are as follows:
Author, AB; Author, CD. Title of journal article. Title of journal, year of publication, volume number, first page-last page.
Nova is committed to maintaining trust in the journal, the value of authorship, and the integrity of science. Authors should be eager to help us maintain these standards. The following guidelines are provided to help authors avoid the appearance of ethical misconduct in their research and to help ensure adherence to the best practices set forth by national and international professional and regulatory bodies.
Plagiarism is a blight on the scientific community and a crime. The unauthorized use or close imitation of another’s language, text, data, ideas, or theories is prohibited. In all instances of authorized use, full credit to and representation of the original author’s work must be provided. It is the authors’ responsibility to secure permission for the use of copyrighted material. Nova uses software during the page proof stage of production to check for instances of plagiarism. Articles will not be accepted for publication by the Publisher until articles are proven not to consist of plagiarized material. The journal will investigate all reports and suspicions of plagiarism. Authors suspected of plagiaristic misconduct will be contacted and given the opportunity to prove the validity of their work and refute the allegations. All instances of proven plagiarism will be reported to the Publisher by the editorial office, and the author’s institute, and other governing bodies will be contacted as necessary. Plagiarized articles already accepted for publication will be cancelled, and plagiarized articles that have already been published will be retracted and denounced in a public erratum.
It is important that all authors and organizations where the research has been carried out have consented to the work’s submission and that all authors have significantly contributed.
In order to establish transparency in research, authors should be sure to provide the following items.
1) Information regarding the source(s) of the work’s funding;
2) All financial and non-financial potential conflicts of interest;
3) A statement of informed consent for all studies that involve human participants;
4) A statements of human rights for all studies that involve human participants;
5) A statement on the humane treatment and proper welfare of all animals involved in the study.
The appropriate statements are provided below. They should be included in the article’s text in a section titled Ethical Compliance. This section should immediately precede the References section.
1) Sources of Funding
Please provide the names of all funding agencies, research grants, and grant numbers.
Source of Funding: This study was funded by ____________________.
2) Potential Conflicts of Interest
Authors are required to disclose all personal and professional relationships and interests that can be viewed as potentially imparting bias in the work. Readers are entitled to this information and to their own conclusions and perceptions of conflict. Potential conflicts could be financial relationships, employment, sponsorships, public holdings, competing interests, spousal interests, personal relationships, personal beliefs, etc.
a) Disclosure of Interest: The authors declare that they have no conflict of interest.
b) Disclosure of Interest:
3) Informed Consent
Study participants have the right to decide how the identifiable personal information gathered on them is used. It is essential that all participants (or guardians) give their written informed consent to participate in the study and its subsequent publication.
Informed consent was obtained from each individual participant involved in this study.
4) Statement of Human Rights
The wellbeing of human subjects takes precedence over the interests of science. If a study involves human participants, authors should include a statement that the study was conducted in accordance with the 1964 Declaration of Helsinki and its subsequent amendments.
This study was conducted in accordance with the 1964 Declaration of Helsinki and its subsequent amendments.
5) Statement of Animal Welfare
All studies that involve animals should contain a statement that the study and its procedures have been approved by their affiliate institutional research ethics committee.
All animals involved in this study were treated in accordance with the ethical standards set forth by the institution at which the study was conducted.
Committee on Publication Ethics
Nova and its editors follow the Codes of Conduct and Best Practice Guidelines set forth by the Committee on Publication Ethics (COPE). These codes and guidelines are valuable instructions that ensure transparency and fairness in research and publishing. The single document provides steps for submissions, peer-review, confidentiality, the creation and maintenance of editorial boards, editorial responsibilities and decision-making, communication policy, appeal procedures, handling complaints and instances of misconduct, quality assurance, publishing corrections and retractions, adherence to national and international ethics guidelines, and many more aspects of the publication process.
The COPE Codes of Conduct and Best Practice Guidelines can be read at the link below. We recommend your familiarity with them while you publish with Nova and any other scientific publisher.
If you notice any ethical misconduct in Nova’s publications, please contact us.
Nova Science Publishers, Inc.
415 Oser Avenue, Suite N
Hauppauge, New York 11788, USA
Phone: (631) 231-7269
Please contact our office using the information above.